bioAffinity Technologies, Inc. (BIAF) has released an update to notify the public and investors about its officers.
On January 26, 2024, Bioaffinity Technologies, Inc. adopted a Management Incentive Bonus Plan to motivate alignment with the company’s strategic goals through competitive annual incentives. The Compensation Committee oversees the Plan, granting awards, setting terms, and determining payouts based on performance. The Committee also issued discretionary bonuses for several executives for 2023, payable in cash and restricted stock, with the stock amount based on the January 31, 2024 stock price. Additionally, an amendment to an executive’s restricted stock award ensures full vesting upon a Change in Control.
For further insights into BIAF corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
